Management of ischaemic heart disease in women of child-bearing age.
Ischaemic heart disease is rare in young women but is expected to increase with increasing average age of child bearing. Diagnosis of myocardial ischaemia in this group is complicated by limited data about maternal and fetal safety of the standard diagnostic tests routinely used in other patients. Management of these patients remains difficult, as many standard treatments, such as beta-blockers and angiotensin converting enzyme inhibitors are pregnancy category C or D, and there is little experience with many of the newer treatments such as coronary artery stenting, clopidogrel and glycoprotein IIb/IIIa inhibitors in pregnancy. An interesting case of a woman, who had an acute myocardial infarction treated with thrombolysis and coronary artery stenting, and who subsequently became pregnant, is reported here, and other published reports regarding the management of coronary artery disease, both acute and chronic, in pregnant women are explored.
Wilson
A M
AM
Melbourne University Department of Medicine, St. Vincent's Hospital, Regent & Princes Streets, Fitzroy, Melbourne, Victoria 3065, Australia. wilsonam@medstv.unimelb.edu.au
Boyle
A J
AJ
Fox
P
P
D000328:Adult; D001241:Aspirin / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D017202:Myocardial Ischemia / Q000175:diagnosis / Q000517:prevention & control*; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000175:diagnosis / Q000517:prevention & control*
D005343:Fibrinolytic Agents; D007004:Hypoglycemic Agents; D007328:Insulin; D001241:Aspirin